Speiser Z, Fine T, Litinetsky L, Eliash S, Blaugrund E, Cohen S
J Neural Transm (Vienna). 2007; 115(1):107-16.
PMID: 17823767
DOI: 10.1007/s00702-007-0811-8.
Mason G, Walker C, Little K
Psychopharmacology (Berl). 1993; 110(1-2):110-4.
PMID: 7870868
DOI: 10.1007/BF02246958.
Sporer K
Drug Saf. 1995; 13(2):94-104.
PMID: 7576268
DOI: 10.2165/00002018-199513020-00004.
Connell D, Middlemiss D, Stone M
Br J Pharmacol. 1980; 68(1):173P-174P.
PMID: 7357187
PMC: 2044075.
Montastruc J, MONTASTRUC P
Br J Pharmacol. 1981; 72(3):411-7.
PMID: 7260484
PMC: 2071595.
DOI: 10.1111/j.1476-5381.1981.tb10991.x.
A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
Dourish C
Br J Pharmacol. 1982; 77(1):129-39.
PMID: 6982090
PMC: 2044650.
DOI: 10.1111/j.1476-5381.1982.tb09278.x.
Evidence for the role of noradrenaline in some effects of quipazine.
Frances H, Lecrubier Y, Puech A, Simon P
Psychopharmacology (Berl). 1980; 67(3):307-10.
PMID: 6770410
DOI: 10.1007/BF00431273.
Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
Jenner P, Marsden C, Thanki C
Br J Pharmacol. 1980; 69(1):69-80.
PMID: 6769527
PMC: 2044189.
DOI: 10.1111/j.1476-5381.1980.tb10884.x.
Differential effects of 5-hydroxytryptamine antagonists on behaviors resulting from activation of different pathways arising from the raphe nuclei.
Segal M, Weinstock M
Psychopharmacology (Berl). 1983; 79(1):72-8.
PMID: 6403968
DOI: 10.1007/BF00433019.
Effects of propranolol on the locomotor stimulation induced by activation of postsynaptic catecholamine receptors.
Hallberg H, ALMGREN O, Engel J, Jonason J
Psychopharmacology (Berl). 1981; 72(3):227-31.
PMID: 6261288
DOI: 10.1007/BF00431821.
Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.
Nurnberger Jr J, Kessler L, Jimerson S, Schreiber J, Hollander E, Tamminga C
Psychopharmacology (Berl). 1984; 84(2):200-4.
PMID: 6239300
DOI: 10.1007/BF00427446.
The effect of propranolol on CSF amine metabolites in psychiatric patients.
King D, Cooper S, Liddle J
Br J Clin Pharmacol. 1983; 15(3):331-7.
PMID: 6189502
PMC: 1427775.
DOI: 10.1111/j.1365-2125.1983.tb01507.x.
Reduced brain serotonergic activity after repeated treatment with beta-adrenoceptor antagonists.
Hallberg H, ALMGREN O, Svensson T
Psychopharmacology (Berl). 1982; 76(2):114-7.
PMID: 6123131
DOI: 10.1007/BF00435263.
Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome.
ORTMANN R, Martin S, Radeke E, Delini-Stula A
Naunyn Schmiedebergs Arch Pharmacol. 1981; 316(3):225-30.
PMID: 6114439
DOI: 10.1007/BF00505653.
Beta-adrenoceptor antagonists: studies on behaviour (delayed differentiation) in the monkey (Macaca mulatta).
Nicholson A, Wright C
Br J Pharmacol. 1980; 68(1):75-82.
PMID: 6101977
PMC: 2044090.
DOI: 10.1111/j.1476-5381.1980.tb10701.x.
Beta-adrenoceptor antagonists in L-tryptophan and L-DOPA induced behavioural syndromes [proceedings].
Buxton D, Friend J, KENT A
Br J Pharmacol. 1980; 68(1):176P-177P.
PMID: 6101976
PMC: 2044063.
DOI: 10.1111/j.1476-5381.1980.tb14546.x.
Early postnatal treatment with propranolol affects development of brain amines and behavior.
Hilakivi L, Taira T, Hilakivi I, Macdonald E, Tuomisto L, Hellevuo K
Psychopharmacology (Berl). 1988; 96(3):353-9.
PMID: 3146769
DOI: 10.1007/BF00216061.
Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine.
Balsara J, Bapat T, Nandal N, Gada V, Chandorkar A
Psychopharmacology (Berl). 1986; 88(3):275-8.
PMID: 2938207
DOI: 10.1007/BF00180824.
The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
Deakin J, Green A
Br J Pharmacol. 1978; 64(2):201-9.
PMID: 708990
PMC: 1668312.
DOI: 10.1111/j.1476-5381.1978.tb17290.x.
The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin.
Belmaker R, Ebstein R, Dasberg H, Levy A, Sedvall G, van Praag H
Psychopharmacology (Berl). 1979; 63(3):293-6.
PMID: 113817
DOI: 10.1007/BF00433565.
